In Depth 1 Dec 2022
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy was a…
Immunocore
- Latest Posts
Best in Biotech 20 Dec 2021
The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European…
Best in Biotech 28 Dec 2020
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at…
Best in Biotech 17 Sep 2020
The Top 10 Biotech Companies Brewing at Oxford
Here are the top biotech companies in Oxford, a city with an old scientific tradition and an enormous output of…
ADVERTISEMENT
News and Trends 4 Mar 2020
Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B
UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to…
News and Trends 20 Nov 2018
Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy
Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore's…
Best in Biotech 20 Feb 2018
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our…
Best in Biotech 27 Dec 2017
The Biggest Biotech News of 2017: What Happened This Year?
Still catching up on news? We've picked out the most exciting things that happened besides clinical results and finance. Here's…
News and Trends 12 Dec 2017
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100 available to patients with uveal melanoma…
News and Trends 13 Nov 2017
World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of the best work being done…
ADVERTISEMENT
News and Trends 13 Nov 2017
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for its TCR immunotherapy IMCgp100 in…
News and Trends 18 Sep 2017
British Unicorn Gets $40M Boost from Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation have injected $40M (€33M) into Immunocore to accelerate the development of its immunotherapies for…
Infographics 13 Sep 2017
The 10 Most Innovative HIV Treatments to Defeat AIDS
This infographic gathers 10 of the best HIV treatments in Europe's pipeline that will help doctors worldwide fight against AIDS…
News and Trends 7 Jun 2017
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO 2017 meeting in Chicago. European…
News and Trends 8 May 2017
Immunocore Boosts its Collaboration with GSK with new Lead Compound
Immunocore has singled out a new lead candidate in its immuno-oncology discovery program with GSK, triggering an undisclosed milestone payment…
Interview 20 Apr 2017
Which EU Immuno-Oncology Company are you Cheering for?
Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around Europe are developing innovative ways…
ADVERTISEMENT
Best in Biotech 15 Mar 2017
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look…
Infographics 13 Feb 2017
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for its potential to cure cancer.…
News and Trends 14 Dec 2016
What do the CAR-T Patient Deaths Mean for the Future of the Field?
Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite…
News and Trends 5 Dec 2016
Video: Chatting with Immunocore about the Potential of Immuno-oncology
At Refresh in Paris, I had the opportunity to ask Eva-Lotta Allan,CBO of one of Europe's hottest companies, Immunocore, some…